Ipamorelin

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue (GHS) that stimulates pituitary GH release through targeted ghrelin receptor activation without affecting other hormones.

• Ipamorelin binds to the ghrelin receptor (GHS-R1a), mimicking natural ghrelin action while exhibiting unique selectivity that avoids cortisol, prolactin, or ACTH elevation seen with other secretagogues like GHRP-6.

• Research demonstrates Ipamorelin’s controlled GH secretion without overstimulation, increasing IGF-1 levels and improving bone density markers while avoiding appetite stimulation typical of ghrelin mimetics.

• Studies confirm sustained effectiveness without receptor desensitization, making it valuable for research in growth hormone deficiency, muscle mass preservation, and age-related metabolic decline.

Ipamorelin provides selective GH stimulation, preserved hormonal balance, and controlled pulsatile release, offering researchers a clean tool for investigating growth hormone regulation without confounding endocrine variables.

Composition: Ipamorelin (5 mg)